Acheson Report
Acheson Report is a significant document in the field of public health and social inequality. Officially known as the Independent Inquiry into Inequalities in Health Report, it was published in 1998 by the UK government. The report was named after its chairman, Sir Donald Acheson, a distinguished epidemiologist and former Chief Medical Officer.
Background
The Acheson Report was commissioned by the newly elected Labour government in 1997, with the aim of reviewing the latest data on health inequalities and suggesting possible policies to reduce them. This was in response to growing concerns about the widening gap in health outcomes between different social groups.
Findings
The Acheson Report identified a strong and persistent gradient in health inequality across the social classes in the UK. It found that these inequalities were not just confined to the poor, but affected all levels of society. The report highlighted the role of poverty, education, employment, housing and diet in determining health outcomes.
Recommendations
The Acheson Report made 39 recommendations for reducing health inequalities. These included policies aimed at reducing income inequalities, improving living standards for the poorest, increasing access to education and employment opportunities, and promoting healthier lifestyles.
Impact
The Acheson Report has had a significant impact on public health policy in the UK and internationally. It has influenced the development of strategies to tackle health inequalities and has been cited in numerous academic studies and policy documents.
Criticisms
Despite its influence, the Acheson Report has been criticised for its focus on social determinants of health, with some arguing that it neglects the role of individual behaviour and lifestyle choices. Others have questioned the effectiveness of its recommendations in reducing health inequalities.
See also
This UK-health related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
